News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|March 25, 2022

Considerations for Moderna's move to get an EUA for the COVID-19 vaccine in young kids

Author(s)Miranda Hester

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

FDA updates Elevidys labeling with boxed warning and revised indication following reports of fatal liver injury

FDA updates Elevidys labeling with boxed warning and revised indication following reports of fatal liver injury

ByMorgan Ebert, Managing Editor

November 14th 2025

Tapinarof cream, 1% (VTAMA) shows early improvements in pediatric atopic dermatitis | Image Credit: © Ruslan Ivantsov - stock.adobe.com.

Tapinarof cream, 1% (VTAMA) shows early improvements in pediatric atopic dermatitis

ByMorgan Ebert, Managing Editor

November 14th 2025

Dupilumab's continued efficacy in pediatric EoE patients, with Joshua Wechsler, MD

Dupilumab's continued efficacy in pediatric EoE patients, with Joshua Wechsler, MD

ByJoshua Wechsler, MD, MSCI

November 12th 2025

Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD

Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD

ByThomas Wallach, MD

November 7th 2025

Odevixibat demonstrates sustained pruritus and bile acid improvements in FIC1 deficiency | Image Credit: © mi_viri - stock.adobe.com.

Odevixibat demonstrates sustained pruritus and bile acid improvements in FIC1 deficiency

ByJoshua Fitch, Senior Editor

November 7th 2025

Latest CME

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Tapinarof cream, 1% (VTAMA) shows early improvements in pediatric atopic dermatitis

Neurodevelopmental disorder risks not increased by prenatal acetaminophen use

Study: Child maltreatment rates declined overall, but disparities persisted across sex and race

FDA updates Elevidys labeling with boxed warning and revised indication following reports of fatal liver injury

Valeria Cohran, MD, highlights specialist-pediatrician collaboration when treating short bowel syndrome-associated intestinal failure

© 2025 MJH Life Sciences^®

All rights reserved.